Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Confe... ( COLUMBUS Ga. May 21 /- Aflac Inco...)

HOME >> MEDICINE >> NEWS

Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008

Date:5/21/2008

COLUMBUS, Ga., May 21 /PRNewswire-FirstCall/ -- Aflac Incorporated (NYSE: AFL) announced today that it will make a presentation at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008.

President and Chief Financial Officer Kriss Cloninger III will represent Aflac Incorporated, and he is scheduled to make a presentation on May 28 at 10:00 a.m. EDT. During the Aflac Incorporated presentation, Mr. Cloninger will discuss the company's outlook for 2008 and its strategy for growth in the U.S. and Japanese insurance markets.

Mr. Cloninger's presentation will be webcast live at the following web address:

http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=AFL&item_id=18 17940

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash where it is needed most when a life-interrupting medical event causes financial challenges. Aflac is the number one provider of guaranteed-renewable insurance in the United States and the number one insurance company in terms of individual insurance policies in force in Japan.

Our insurance products provide protection to more than 40 million people worldwide. Aflac has been included in Fortune magazine's listing of America's Most Admired Companies for seven years and in Fortune magazine's list of the 100 Best Companies to Work For in America for ten consecutive years. Aflac has also been recognized three times by both Fortune magazine's listing of the Top 50 Employers for Minorities and Working Mother magazine's listing of the 100 Best Companies for Working Mothers. Aflac Incorporated is a Fortune 500 comp
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Aflac Announces Resignation of U.S. Marketing Officer
2. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
3. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
4. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
5. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac to Sponsor Iron Girl
8. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
9. Aflac Incorporated Announces Fourth Quarter Results
10. Training Magazine Applauds Aflacs Employee Learning Programs
11. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference

Post Your Comments:

(Date:11/9/2009)...arkett Sports, the worldwide leader in sports surf...offering with a more complete and innovative range...sports flooring experts and the launch of www.tar...(PRWEB) November 9, 2009 -- Tarkett Sports, redesi... products includes hardwood and synthetic basketba...

(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medi...developer, manufacturer and,marketer of medical de...dited,financial results for the third quarter and ...lights for Operations as of September 30, 2009, ...llion, an increase of, 3.1% over the third q...

(Date:11/9/2009)...RNewswire/ -- The Churchill Centre today announc...p to J.W. "Bill" Marriott for his lifelong commitm...e market practices and fostering an open and trans...receive his award at a ceremony and dinner on Tues...ns Hotel. ,, "This is a testament to how Bill ...

(Date:11/9/2009)...nlargement, study finds , , MONDAY, Nov....tor for left atrial enlargement, which increases t...a new study shows. , Atrial fibrillation is the...t rhythm or heartbeat). , Researchers analyzed...rmany who were followed for 10 years. The study au...

(Date:11/9/2009)...t both eye conditions are age-related, researchers... -- Cataract surgery doesn,t appear to speed the p...D), according to a new study that challenges the b...ns the other. , "Because both conditions are st... also have AMD," wrote Li Ming Dong, of Stony Broo...

[0] Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website [0] Mindray Announces Third Quarter 2009 Financial Results [0] J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership [0] Obesity Seems to Alter Heart Structure [0] Cataract Surgery Doesn't Worsen Macular Degeneration: Study

...visor and speaker Michael Morgan is helping U.S., ...d Middle Eastern and Islamic investors, business, ...ts tap into one of the most active investment sour...ities for everyone to find new markets, partners a...

...HO: Myles Druckman, MD, a leading disease outbr... Dr. Druckman has been interviewed by, ... CNN, CNBC, and, The Washington Post, a... including:, * The WHO raising ...

...r. Joel Selanikio,s innovative technology is not o...ublic health system around the world. Merging his ...ne and public health with his business partner,s b...lth data in developing nations. Officially establi...

...Biosystems, Inc. (OTC Bulletin Board: WGBS), a lea...s systems, today announced the signing of a resear...nter scientists for WaferGen,s SmartChip(TM) Real-... for Genome Sciences and Policy at Duke Universit...

...n and Narrows Earnings Guidance to Upper End of Ra...Hospira, Inc. (NYSE: HSP ), a leading global spe...any, today reported results for the first quarter ...rtain specified items as described later in this p...

...Associates Outlines China ,s , Stimulus Plan a... has announced a $124 billion stimulus package t... calls for digital hospitalization, adoption of el...tual healthcare services that can help overcome di...

Global Advisor and Speaker Explains Middle East Investors, Politics, Culture Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu Open source mobile technology software reinventing health care in developing countries WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System Hospira Reports First-Quarter 2009 Results China Seeks to Transform Healthcare Sector with Information Technology

(Date:11/9/2009)...ov. 9 ISTA Pharmaceutica...nal results from the Company,s Bepreve(TM) (bepota...linical studies. These results were presented in ...American College of Allergy, Asthma & Immunolo...presentation titled, "Treatment of Ocular Itching ...

(Date:11/9/2009)... Mass., Nov. 9 Decision Resources,...firms for pharmaceutical and healthcare issues, fi...eceptor 2 (HER2) targeting therapies -- which incl...ippon Kayaku,s Tykerb/Tyverb -- were the highest-s...inued uptake of Herceptin and Tykerb/Tyverb and th...

(Date:11/9/2009)...PHIA, Nov. 9 Shire plc...ty biopharmaceutical company, today announced the ...ded Release Tablets in pharmacies across the Unite...peractivity Disorder ( ADHD ) in children and ad...mulation of guanfacine, is the first and only nons...

Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2 ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3 Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7 BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 1 BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 2 Research Councils UK sign groundbreaking MoU with Brazil 9928 1 Research Councils UK sign groundbreaking MoU with Brazil 9928 2 Research Councils UK sign groundbreaking MoU with Brazil 9928 3 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 1 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 2 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 3 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 4 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 5

[0] ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)[0] Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 [0] Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide

...y 15 Cytopia Limited,(ASX: CYT) today announced t...n on CYT997 at the 2008 Annual Meeting of the Amer...ccessible to the public via ASCO,s,website (http:...DT)., The oral presentation, entitled "Phase I ev... disrupting agent, in patients with advanced cance...

... Schering-Plough,Corporation (NYSE: SGP ), a lea...nic hepatitis C virus (HCV) infection, announced t...PEGINTRON(TM) (peginterferon alfa-2b) and,REBETOL(...s boceprevir, the,company,s investigational oral H...th annual Digestive Disease Week (DDW) meeting to ...

Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7

Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting

FemoStop

VasoSeal VHD KIT 6

VasoSeal VHD KIT 4

Hemapatch Knitted

Medicine Products:

FemoStop VasoSeal VHD KIT 6 VasoSeal VHD KIT 4 Hemapatch Knitted

Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Confe...( COLUMBUS Ga. May 21 /- Aflac Inco...),Health